Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
249 - The Best Audit Advice Nobody Told Me
|
Aug 05, 2026 |
|
248 - What Is a Quality Unit? QA vs. QC Explained
|
Jul 29, 2026 |
|
247 - Why Everyone in Pharma and MedTech Should Work in Quality
|
Jul 22, 2026 |
|
246 - The 3 Ways to Structure a Quality Management System (Centralized vs. Federated vs. Decentralized)
|
Jul 15, 2026 |
|
245 - Reducing a 14-Step Emergency Injection to a Two-Step Auto-Injector
|
Jul 08, 2026 |
|
244 - 5 Critical Quality Differences Between Drugs and Devices
|
Jul 01, 2026 |
|
243 - Why Kitting A Finished Medical Device with a Drug Create So Much Work
|
Jun 24, 2026 |
|
242 - Pharma/MedTech Audits: 6 Strategies for Choosing Where to Start
|
Jun 17, 2026 |
|
241 - ICH Q14 Explained: Have We Been Validating Methods Backwards?
|
Jun 10, 2026 |
|
240 - ICH Q13: Continuous Manufacturing, Batches, Residence Time Distribution and Control Strategy
|
Jun 03, 2026 |
|
239 - ICH Q12: What’s Binding? Established Conditions and Post-Approval Changes
|
May 27, 2026 |
|
239 - ICH Q11 in 6 Minutes
|
May 20, 2026 |
|
238 - 6 Audit Strategies Every Auditor Should Know
|
May 13, 2026 |
|
237 - ICH Q10: The Pharmaceutical Quality System
|
May 06, 2026 |
|
236: ICH Q9: Quality Risk Management (QRM) + ISO 14971 Differences
|
Apr 29, 2026 |
|
235 - ICH Q8: How Pharmaceutical Development Actually Works
|
Apr 22, 2026 |
|
234 - ICH Q7: The GMP Framework for API Manufacturing
|
Apr 15, 2026 |
|
233 - Most Teams Misunderstand Specifications | ICH Q6
|
Apr 08, 2026 |
|
232 - MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk
|
Apr 01, 2026 |
|
231 - Audit Findings Explained: Nonconformity vs Observation (CQA)
|
Mar 25, 2026 |
|
230 - How Pharma Misses Critical Market Signals with Joe Luminiello
|
Mar 23, 2026 |
|
229 -Outsourcing Analytical Testing: What Sponsors Get Wrong in Combination Products
|
Mar 11, 2026 |
|
228 - ICH Q5 EXPLAINED: Why Regulators Treat Biologics Differently
|
Mar 04, 2026 |
|
227 - When Should You Open a CAPA? Triggers, Human Error, and Investigation Basics
|
Feb 24, 2026 |
|
226 - Navigating China NMPA Medical Device Requirements | Standards, GMP Updates, Agents & Classification
|
Feb 18, 2026 |
|
226 - ICH Q4 Explained: How Pharmacopeial Methods Are Accepted Across Regions
|
Feb 11, 2026 |
|
225 - ICH Q3A, Q3B, Q3C, Q3D and Q3E - EXPLAINED in 10 Minutes
|
Feb 04, 2026 |
|
224 - ICH Q2 Explained: What Analytical Validation Really Requires
|
Jan 28, 2026 |
|
223 - What’s Changing in ICH Q1 and What Isn’t: Understanding Stability Expectations
|
Jan 21, 2026 |
|
222 - How ICH Guidelines Are Organized: Understanding the Q, S, E, and M Series
|
Jan 14, 2026 |
|
221 - What Is ICH and Why It Matters
|
Jan 07, 2026 |
|
220 - Managing Oneself, Reflections and a New Series on ICH
|
Dec 31, 2025 |
|
219 - FDA PreCheck and the Future of Inspections: PAI to Pre-Readiness
|
Dec 24, 2025 |
|
218 - ICH Q13: Continuous Manufacturing EXPLAINED (Batch vs. Continuous)
|
Dec 17, 2025 |
|
217 - 5 Fixable Problems Holding Back Drug–Device Programs
|
Dec 10, 2025 |
|
216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke
|
Dec 03, 2025 |
|
215 - Why Aren’t Technical People Leading Drug-Device Audits?
|
Nov 26, 2025 |
|
214 - The Best 5 Certifications for ANY Quality Career Path (CQE, Green Belt, CQA & More)
|
Nov 19, 2025 |
|
213 - From Generic Underdog to Billion‑Dollar Exit: How Usman Ahmed Built & Sold a Sterile Injectable Site
|
Nov 12, 2025 |
|
212 - What 6 of the World’s Biggest Companies Taught Him About Combination Products
|
Nov 05, 2025 |
|
211 - Inside FDA’s Office of Combination Products: History, PMOA, and What’s Next for Combination Products with Mark Kramer
|
Oct 30, 2025 |
|
210 - The 8 Roles You MUST Understand in Pharma & MedTech
|
Oct 22, 2025 |
|
210 - How AI Is Rewriting GMP: Smarter CAPA, PAT, DOE, and Continuous Yield
|
Oct 15, 2025 |
|
209 - ALCOA++ EXPLAINED | What Everyone Gets Wrong About Data Integrity with Monika Andraos
|
Oct 08, 2025 |
|
208 - How Drugs Are Designed, Targets, Phenotypes, and Structure Based Design
|
Oct 01, 2025 |
|
207 - What 99.999% Reliability Really Means
|
Sep 24, 2025 |
|
206 - Will AI Decide Your Next Drug/Device Approval?
|
Sep 17, 2025 |
|
205 - Why Less Than 20% of Companies Have Started Quality 4.0
|
Sep 11, 2025 |
|
204 - The Dictionary & Thesaurus of Combination Products (Finally Explained) with Susan Neadle
|
Sep 03, 2025 |
|
203 - Drug Delivery, Platforms, IP Battles, Supply Chain Risks with Jim Collins
|
Aug 27, 2025 |
|
202 - Becoming an Expert in the Work Nobody Wants to Do/Design, Risk, and the Messy Middle of Combination Products w/Joey Frechin
|
Aug 20, 2025 |
|
201 - Inside a $300M FDA Remediation, Lessons from Zimmer to EpiPen Warning Letters, 99.999% Reliability and Quality 4.0
|
Aug 13, 2025 |
|
200 - MedTech and Pharma After 200 Episodes…..
|
Aug 06, 2025 |
|
199 - How Modeling Can Cut in Half for Combination Products, V&V 40, and Cutting Dev Time with Mark Burchnall
|
Jul 30, 2025 |
|
198 - QMSR Explained, ISO 13485 Compared, and 5 Key Things You Might’ve Missed
|
Jul 23, 2025 |
|
197 - Quality Agreements Explained: How to Protect Yourself When Things Go Wrong
|
Jul 16, 2025 |
|
Combi Crumbs: Clinical Trials 101 – From Safety to Strategy
|
Jul 12, 2025 |
|
196 - How to Win Your First 90 Days in Pharma and MedTech
|
Jul 09, 2025 |
|
195 - Clinical Trial Design, Oncology Innovation & Decentralized Trials with Archana Sah
|
Jul 02, 2025 |
|
194 - Drug Delivery Innovation, Networking in Pharma, and Building a Career That Matters with Mike Denzer
|
Jun 25, 2025 |
|
193 - Bioengineering Grads: Here’s What Recruiters Actually Want to See in 2025
|
Jun 18, 2025 |
|
192 - What Is a Drug/Device Combination Product? (Non-Technical, Under 5 Minutes)
|
Jun 11, 2025 |
|
191 - If It’s Not ALCOA+, It Didn’t Happen: The Real Meaning of Data Integrity
|
Jun 04, 2025 |
|
190 - Harmony, Not Sameness: What Drug-Device Teams Keep Getting Wrong
|
May 28, 2025 |
|
189 - FDA, ISO, ICH, USP, PDA - What Are These Groups and Why Do They Matter?
|
May 21, 2025 |
|
188 – Certified Quality Auditor(CQA) and Audits in the Future
|
May 14, 2025 |
|
187 - Why Drug and Device Development Use Different Playbooks (QbD vs. Design Controls Explained)
|
May 07, 2025 |
|
186 - 4 Ways to Future-Proof Your Career in Pharma, Medical Devices and BioTech
|
Apr 30, 2025 |
|
185 - ISO 10013, Document Control in Pharma & Devices: SOPs, Work Instructions, and RACI Done Right with Aaron Snyder
|
Apr 23, 2025 |
|
184 - Program Management in Pharma & Devices: Phase Gates, Risk Planning, and Project FMEAs Explained
|
Apr 16, 2025 |
|
183 - GxP Explained: A Complete Guide to Good Manufacturing, Clinical, Laboratory, and Distribution Practices for Regulated Products
|
Apr 09, 2025 |
|
182 - 7 Powerful Ways to Find Amazing Mentors in Medical Devices and Pharma
|
Apr 02, 2025 |
|
181 - Can Ampoule Drug Delivery Systems REVOLUTIONIZE the Industry?
|
Mar 26, 2025 |
|
180 - MIT Leadership Expert Reveals Management Secrets for Scientists!
|
Mar 19, 2025 |
|
179 - Quality is NOT Everyone’s Job—Why That’s a GOOD Thing
|
Mar 12, 2025 |
|
178 - CAPA Face-Off: Pharma vs. MedTech – Key Differences You Need to Know
|
Mar 05, 2025 |
|
177 - The GXPs That Run Pharma & Medical Devices: GMP, GDP, GCP, GLP, GVP, GAMP EXPLAINED
|
Feb 26, 2025 |
|
176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski
|
Feb 19, 2025 |
|
175 - Hearing Aid Innovations and Why Hearing Loss Is More Dangerous Than You Think with Bill Facteau
|
Feb 12, 2025 |
|
174 - How GLP-1s Like Ozempic & Wegovy Are Changing Pharma with Ben Locwin
|
Feb 05, 2025 |
|
173 - Shelley Amster on 45 Years Trailblazing: IUD’s, Breaking Barriers in IVF & Women's
|
Jan 29, 2025 |
|
172 - Regulatory AI Innovations, Drugs@FDA Database, Regulatory Intelligence Strategies, Human Factors Insights, and Smarter Submission Approaches with Doug Mead
|
Jan 22, 2025 |
|
171 - Are Pre-Filled Syringes with Vaccines, Biologics, Generics, or Small Molecules considered Combination Products?
|
Jan 13, 2025 |
|
170 - The #1 Secret to Understanding ISO 13485 (You’ll Wish You Knew Sooner)
|
Jan 08, 2025 |
|
169 - Should You Study Bioengineering in 2025? My Decade-Long Perspective
|
Jan 01, 2025 |
|
168 - Audits, Audits, Audits: Why They Matter in Pharma, Medical Devices, and Personal Growth
|
Dec 25, 2024 |
|
167 - Smart Pills, Digital Drug Delivery Systems, and How Technology is Reshaping Pharma and Healthcare with Timothy Aungst
|
Dec 18, 2024 |
|
166 - Sync or Sink: 3 Levels of Harmonization for Combination Product Success
|
Dec 11, 2024 |
|
165 - Anatomy of a Target Product Profile(TPP): All 10 Sections EXPLAINED with Marta New
|
Dec 04, 2024 |
|
164 - Tiny Particles, Big Impact: Breaking down USP 788 & USP 790
|
Nov 27, 2024 |
|
163 - ICH Q12, Established Conditions, Post-Approval Changes, PACMP's, and the Pharma Lifecycle
|
Nov 20, 2024 |
|
162 - Philip Crosby’s 5 Bad Beliefs About Quality (And How to Avoid Them)
|
Nov 12, 2024 |
|
161 - ISO 14971 and ICH Q9 EXPLAINED: Risk Management Frameworks in Medical Devices, Pharma and Combination Products
|
Nov 06, 2024 |
|
160 - Drug Tech Transfer vs. Device Design Transfer EXPLAINED!
|
Oct 30, 2024 |
|
159 - Centralized, Decentralized & Federated Quality Models, McKinsey Study, and QA vs. QC with Ben Locwin
|
Oct 23, 2024 |
|
158 - 3 Years Straight of Drug/Device Podcasting, Guarding the Process, and the Future of the Show
|
Oct 16, 2024 |
|
157 - Design Inputs that Don't Suck, Risk Control Measures and Problems with Verification with Chuck Ventura
|
Oct 09, 2024 |
|
156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar
|
Oct 02, 2024 |
|
155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach
|
Sep 25, 2024 |
|
154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell
|
Sep 18, 2024 |
|
153 - USP 382, Elastomeric Component Functional Suitability, Delivery Systems, Spikes, IV Bags and Alternate Packaging with Fran Degrazio
|
Sep 11, 2024 |
|
152 - Global Medical Device Podcast Interview: Behind the Combinate Podcast, Combination Products Why, Unique Episodes, Pyramids and Books with Etienne Nichols & Subhi Saadeh
|
Sep 04, 2024 |
|
151 - Primary Packaging/Container Closure Change Guidance, Post-Approval Changes, Sponsor/Supplier Relationships, Purchasing Controls and Tubular vs. Molded Glass with Fran Degrazio
|
Aug 28, 2024 |
|
150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar
|
Aug 21, 2024 |
|
149 - Lyophilization/Freeze-Drying Equipment, Environment, Cleaning, Loading, Automation, Refrigeration, Vacuum, Filtration, and Potent/Non-Aqueous Considerations with David Simoens
|
Aug 14, 2024 |
|
148 - Standards Applicability Assessments, Atomic Requirements, Documentation and Timing with Leo Eisner
|
Aug 07, 2024 |
|
147 - URRA Draft Guidance, uFMEA's, Design Validation, HF Summative, Comparative Analysis, Threshold Analysis and Compelling Technical Arguments with David Grosse-Wentrup
|
Jul 30, 2024 |
|
146 - Lyophilization/Freeze-Drying, Filling, Sublimation, Disorption, Backfilling, Stoppers, Vacuum and Water's Triple Point with David Simoens
|
Jul 24, 2024 |
|
145 - Regulatory Policy, Advocacy, Legislation, Combination Product Regulatory Harmonization, IMDRF and Ikigai with Ryan Hoshi
|
Jul 17, 2024 |
|
144 - Auto-Injectors, Pen Injectors, Challenges in Product Development, Sponsors and CDMO's with David DeSalvo
|
Jul 10, 2024 |
|
143 - New FDA Draft Guidance: Essential Drug Design Outputs with Alan Stevens and Rumi Young
|
Jul 03, 2024 |
|
142 - Material Qualification in Drugs vs. Devices, PPAP, APQP, Quality Tools and Purchasing Controls with Ben Locwin
|
Jun 26, 2024 |
|
141 - Lessons from the Life and Legacy of Quality Guru H. James Harrington (1929-2024)
|
Jun 19, 2024 |
|
140 - Medical Device & Diagnostics Cybersecurity, 3rd Party Software, SBOM's, Evaluating Skill and Mindset with Christian Espinosa
|
Jun 12, 2024 |
|
139 - FDA Platform Guidance, EMA Q&A Guidance for Drug Device Combinations, USP and Sugar Badger 50k Race Recap with Subhi Saadeh
|
Jun 05, 2024 |
|
138 - Operations vs. Quality, KPI's, Management Controls, Process Improvement, Balancing Capability/Capacity and Improvement Culture with Larry Mager
|
May 29, 2024 |
|
137 - The 3 Levels of Reliability, Fault Tree Analysis, Needle Safety, Emergency Use, and Risk Management with Capt. Alan Stevens
|
May 22, 2024 |
|
136 - Systems Engineering for Combination Products, User Needs, Design Inputs, Design Changes, Risk Management Files and Avoiding HUGE Traceability Mistakes with Chuck Ventura
|
May 15, 2024 |
|
135 - Combination Products Mindset, MDUFA and Combination Products, FDA Hierarchy, Supplier Management, Surprises in Industry, and Culture with Tony Watson
|
May 08, 2024 |
|
134 - ISO62304, Software Development Process, SaMD, Closed Loop Systems, Complexities with Cloud and Better Software in MedTech with Richard Koch
|
May 01, 2024 |
|
133 - A Year of Saying No, Advice & Good MedTech Consulting, Humility in Leadership, andToxicity in Teams with Devon C. Campbell
|
Apr 24, 2024 |
|
132 - IEC 60601, A Life Without Standards, Evolution of Standards, Standards Development, and Emerging Technologies with Leo Eisner
|
Apr 17, 2024 |
|
131 - Novel Sterilization Methods for Drugs, Devices & Combination Products, EMA Decision Tree/Assessing Aseptic Filling and Sterility Priniciples with Jeanne Moldenhauer
|
Apr 10, 2024 |
|
130 - QMSR Changes to Traceability/Reporting, Independent Reviewer & Risk Management, Learning New Regulations and MDSAP with Aaron Snyder
|
Apr 03, 2024 |
|
129 - Combination Products, Infusion Pumps and Recalls, Responding to Health Disasters with Public Health Service, and FDA Rule-making Process with Captain Alan Stevens
|
Mar 27, 2024 |
|
128 - Former FDA Inspector and Managing Consultant, Vin Cafiso: Cadavers/Autopsies, Tales from FDA Inspections, Understanding the QMSR, and Quality Culture
|
Mar 20, 2024 |
|
127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal
|
Mar 13, 2024 |
|
126 - Combination Products Collaboration, Turnover on MedTech/Pharma Project Teams, and Lessons from working with Intel's CEO with Mat Stratton, Founder of Coalition Ltd
|
Mar 06, 2024 |
|
125 - Unpacking the Quality Management System Regulation(QMSR) Final Rule with Subhi Saadeh
|
Feb 28, 2024 |
|
124 - 5 Steps to Becoming a Phenom Quality Pro with Andy Robertson
|
Feb 21, 2024 |
|
123 - Uncovering HUGE Quality Issues, Inspection Readiness in 2024, Data Integrity, AlCOA+/PIC/S and Critical Thinking in Quality Management with Peter Baker
|
Feb 14, 2024 |
|
122 - Intricacies of Joint Audits, Rx360, Supply Chain Security, and Networking in Pharma/MedTech with Jim Fries
|
Feb 07, 2024 |
|
121 - Bench Scientist to Commercial Leader, Amgen in the early days, Challenges in Commercialization, Working in Startups vs. Large Companies, and Silos with Sayed Badrawi
|
Jan 31, 2024 |
|
120 - EU MDR R&R: What's the difference between Legal Manufacturer, Authorized Rep, PRRC, Importer and Distributor? with Founder of Easy Medical Device, Monir El Azzouzi
|
Jan 24, 2024 |
|
119 - What are the basics of Clean Rooms, RABS and Isolators in ISO14644 and EU Annex I? with David Simoens
|
Jan 18, 2024 |
|
118 - What are Drug/Device Master Files and When to Use for Combination Product Submissions? with Doug Mead
|
Jan 10, 2024 |
|
117 - Post Market Surveillance, Safety Reporting, Databases, Platforms Health Hazards Assessments and Product Responsibilities with Khaudeja Bano
|
Jan 03, 2024 |
|
116 - Gas Sterilization, ETO, Pre-Conditioning, Materials, Different Gases, Bioburden, Validation, and Safety with Jeanne Moldenhauer
|
Dec 27, 2023 |
|
115 - Bottle of Lies, Generic Drugs Quality, Ranbaxy, Audits, and Inspiring Quality Pros with NYT Best-Selling Author, Katherine Eban
|
Dec 20, 2023 |
|
114 - Irradiation Sterilization, Gamma, X-Ray, E-Beam, Dosimeters, and Combination Products with Jeanne Moldenhauer
|
Dec 13, 2023 |
|
113 - Pharma/MedTech Market, Why Good People Leave, Finding Motivation, Onshoring in Pharma and Motivation with Ira Mann
|
Dec 06, 2023 |
|
112 - Steam Sterilization, Moist/Dry Heat, Biological Indicators, Cycle Development, Validation and Parametric with Release with Jeanne Moldenhauer
|
Nov 29, 2023 |
|
111 - 7 Books to level up for MedTech, BioTech and Combination Product Professionals with Subhi Saadeh
|
Nov 22, 2023 |
|
110 - CXO/CDMO in the future, Supply Chain, Reverse Knowledge Transfer, Trust and Fashionisity with Ben Locwin
|
Nov 15, 2023 |
|
109 - Protecting Patients at All Costs, Being a CQO in Big Pharma, Supply Chain Security and Generic Drugs with Martin Van Trieste
|
Nov 08, 2023 |
|
108 - Clinical Interpretation, Non-Clinical and Clinical CTD Modules 4 & 5, Pre-IND/IND and Dossiers with Margaret Jenkins
|
Nov 01, 2023 |
|
107 - Distilling Decades of MedTech Data, Generative AI, and Doing Without Tribal Knowledge with Michelle Wu
|
Oct 25, 2023 |
|
106 - FOIA, FDA Modernizing 510(k) Program, De Novo Submissions, and more databases with Michelle Lott
|
Oct 24, 2023 |
|
106 - Temperature Mapping, Validation, Data Loggers, Cold Chain, Monitoring and Commissioning with Nathan Roman
|
Oct 11, 2023 |
|
105 - Triathlon: The Combination Products of Sport, 8 Lessons from Ironman Chatanooga and 100 Episodes with Subhi Saadeh
|
Oct 04, 2023 |
|
104 -New FDA Guidance, HF vs. Design Validation, Critical Tasks & Pre-IND HF Studies with Sara McNew
|
Sep 27, 2023 |
|
103 - Prescription Reconciliation, Medication Error Reduction, Automated Home Care, Assisted Robotics, Patient Behavioral Monitoring, and the future of Clinical Trials with Charles Gellman
|
Sep 20, 2023 |
|
102 - Human Error, Doing Quality Differently, Defining Accountability, Written Human Guidance, Blue Line vs. Black Line and Categorizing Deviations with Amy Wilson and Cliff Berry
|
Sep 13, 2023 |
|
101 - Micro-Array Patches, Combination Products in Australia, Differences between TGA and RoW, Novel Delivery Systems, and Clinical Trials with Megan Polidano
|
Sep 06, 2023 |
|
100 - PQMCoach, Our First Recording, Quality (Big Q/little q), Why Predictive Quality Management, and Communicating Quality with Larry Mager
|
Aug 30, 2023 |
|
099 - Medical Device vs. Medicinal Product Reviews in the EU, Working at MHRA, Notified Bodies, EU MDR, ICH Q6 and Writing All About It with Janine Jamieson
|
Aug 23, 2023 |
|
098 - MedTech vs. Aerospace Risk Management, AFAP vs. ALARP/ALARA, Quantifying Benefit, Risk Control Measures, and Risk Management Reports with Bijan Elahi
|
Aug 16, 2023 |
|
097 - Predictive Quality, Business Process Capabilities, 3 Lines of Quality Defense, TOC, COSO and Business Risk with Larry Mager
|
Aug 09, 2023 |
|
096 - Pharma Waste Management, Sustainability, What Happens to Sharps, Disposal and Zero Waste with Heather Johnson
|
Aug 02, 2023 |
|
095 - How FMEA fits into ISO14971, Probabilities, Severity of Harm, RPN's, pFMEA's and making it simpler with Naveen Agarwal
|
Jul 26, 2023 |
|
094 - Connected Combination Products, Product Traceability, Regulating New Products, Pre-Determined Changes and AI/ML with Rumi Young
|
Jul 19, 2023 |
|
093 - Combination Products Handbook Part 2: Supplier Management, Drug/Device Analytical Testing, Biologics, Digital/Connected Health and Changing Regulatory Landscape with Susan Neadle
|
Jul 12, 2023 |
|
092 - Putting it all together: Drug cGMP’s 210/211/ICH and Device QMS 820/ISO13485 with Aaron Snyder
|
Jul 05, 2023 |
|
091 - Combination Products Handbook Part 1: Foundation, Learning from the process, Case Studies and Book Q&A with Susan Neadle
|
Jun 28, 2023 |
|
090 - Software Validation, Automation, No-Code Quality Tools and QMS with Harsh Thakkar
|
Jun 21, 2023 |
|
089 - Talking HealthTech Podcast, Consistency, Australian Innovation in HealthTech, Content, and Community with Peter Birch
|
Jun 14, 2023 |
|
088 - Production Part Approval Process(PPAP) with Subhi Saadeh
|
Jun 07, 2023 |
|
087 - From Crime Reporting to Regulatory Affairs and On/Off The Record with Ferdous Al-Faruque
|
May 31, 2023 |
|
086 - Elastomers - Stopper and Plunger Manufacturing, Processing and USP 381/382 with Fran DeGrazio
|
May 24, 2023 |
|
085 - Digital Innovation, Proteomics, Core & Non-Core Innovation, Consulting after Academia, Democratizing Access and Clinical Trials with Jacob Laprote
|
May 17, 2023 |
|
084 - Drug Discovery, Candidate Selection, Pre-Clinical Development, IND Submissions, Administration Route Selection, TPP and Toxicology with Marta New
|
May 10, 2023 |
|
083 - Holistic Approach to Container Closure Integrity, Capping/Crimping, RSF, and Annex I/USP 1207 Requirements with Derek Duncan
|
May 03, 2023 |
|
082 - CTD Structure for Combination Products, US vs. EU Submissions and Regulatory R&R with Niedre Heckman
|
Apr 26, 2023 |
|
081 - ISO TC 84, ISO11608, Committee Work and Advancing the State of the Art with Bob Nesbitt
|
Apr 19, 2023 |
|
080 - 9 CCI Tests in 10 Minutes, Probabilistic vs. Deterministic, and CCI vs. Permeation with Derek Duncan
|
Apr 12, 2023 |
|
079 - How FDA Reviews Combination Products, Policy, EPR's, and Harmonization with Rumi Young
|
Apr 05, 2023 |
|
078 - Prevention is Not New, Incentives in Health Care, and Integrated Combination Products with Ramin Rafiei
|
Mar 29, 2023 |
|
077 - 8 Databases and How To Use Them with Michelle Lott
|
Mar 22, 2023 |
|
076 - GMP Training, Competence, Human Error and Mentorship with Joanna Gallant
|
Mar 15, 2023 |
|
075 - Shortages, Pricing, Mastering New Skills, and Building Deep Understanding with Ben Locwin
|
Mar 08, 2023 |
|
074 - Article 117, EU MDR extension, Notified Body Opinions, Timing and Interaction with Christiana Hoffman
|
Mar 01, 2023 |
|
073 - Anatomy of a Hazard, Clifton Ericcson, ISO 14971/24971 Risk Management with Naveen Agarwal
|
Feb 22, 2023 |
|
072 - OXO PFS, Drug/Device Usability, Toothbrushes for Children, Epicurious Series and Baseball with Dan Formosa
|
Feb 15, 2023 |
|
071 - Steel Industry to MedTech & Important Quality Systems with Etienne Nichols
|
Feb 08, 2023 |
|
070 - The First Auto-Injectors, ISO-11608 History, and Managing Product with Paul Jansen
|
Feb 01, 2023 |
|
069 - EU MDR Extension with Michelle Lott
|
Jan 25, 2023 |
|
068 - Benefit/Risk Ratios, PRRC, and Mythical Medical with David Rutledge
|
Jan 18, 2023 |
|
067 - mRNA, Flu Vaccines, Good Presentations, and Non-Linear Career Paths with Jane M. True
|
Jan 11, 2023 |
|
066 -Scientist to CSO, Learning QA/RA & Marketing, and Saying Yes to Oppurtunities with Fran DeGrazio
|
Jan 04, 2023 |
|
065 - "8 Quality Lessons from Losing 100 Lbs " with Subhi Saadeh
|
Dec 28, 2022 |
|
064 - Pharma and Medical Device Development Processes, DFSS and Design Reviews with Skip Creveling
|
Dec 21, 2022 |
|
063 - Combination Products Regulatory, Going Wide, and Patient Impact with Niedre Heckman
|
Dec 14, 2022 |
|
062 - Reimbursement in Europe, Access, Rebates, and Negotiation with Stefan Walzer
|
Dec 07, 2022 |
|
061 - Taguchi, Pugh, DFSS, Robust Design and Tolerancing with Skip Creveling
|
Nov 30, 2022 |
|
060 - Why People Leave, Starting Elemed and Trusted Advisory with Elena Kyria
|
Nov 23, 2022 |
|
059 - Literature Review, EU MDR CER’s, and Being Problem Driven with Ethan Drower
|
Nov 16, 2022 |
|
058 - PMSR Globally, Different Clinical Roles and Risk Management with Khaudeja Bano
|
Nov 09, 2022 |
|
057 - Conferences, Expos, LinkedIn and Launching a Podcast with Rizwan Chaudhrey
|
Nov 02, 2022 |
|
056 - "Non-Promotional Compliance" with Darshan Kulkarni
|
Oct 26, 2022 |
|
055 - "Critical Tasks and Knowledge Tasks" with Alexandra Benbadis
|
Oct 19, 2022 |
|
054 - "EUDAMED" with Richard Houlihan
|
Oct 12, 2022 |
|
053 - "Duct Tape and Bubble Gum" with Chris Tsai
|
Oct 05, 2022 |
|
052 - “All Work is Process” with Larry Mager
|
Sep 28, 2022 |
|
051 - "EU MDR" with Bassil Akra
|
Sep 21, 2022 |
|
050 - "When No One is Listening" with James Somauroo
|
Sep 14, 2022 |
|
049 - "What Does the Data Say?" with Shannon Hoste
|
Sep 07, 2022 |
|
048 - "Materials" with Hsinjin Yang
|
Aug 31, 2022 |
|
047 - "Truthful Not Misleading" with Darshan Kulkarni
|
Aug 24, 2022 |
|
046 - "Inflation Reduction Act" with Sarfaraz Niazi
|
Aug 17, 2022 |
|
045 - "Combination Products around the Globe" with Susan Neadle
|
Aug 10, 2022 |
|
044 -“Market Access” with Kasem Akhras
|
Aug 03, 2022 |
|
043 - “Half Knowledge Can Hurt” with Shadeed Salam
|
Jul 27, 2022 |
|
042 - “Reproducible within Limits”
|
Jul 20, 2022 |
|
041 - “Health Citizenship” with Jane Sarasohn Kahn
|
Jul 13, 2022 |
|
040 - “Good Science is Good Science” with Ben Locwin
|
Jul 06, 2022 |
|
039 - "The Camera Didn't Make the Artist Obsolete" with John Nosta
|
Jun 29, 2022 |
|
038 - "Clinical Trials" with Dan Sfera
|
Jun 22, 2022 |
|
037 - Reflections #1 - (Episodes 001-25)
|
Jun 15, 2022 |
|
036 - "Those Moments Keep You Grounded" with Yousef Arman
|
Jun 08, 2022 |
|
035 - “Safety is Safety” with Khaudeja Bano
|
Jun 01, 2022 |
|
034 - "Agent" with Mitch Robbins
|
May 25, 2022 |
|
033 - "Specialization" with Erik Barkley
|
May 18, 2022 |
|
032 - “Quality is Free”
|
May 11, 2022 |
|
031 - "The Five Stages Of Regulatory Grief" with Michelle Lott
|
May 04, 2022 |
|
030 - "Why Don't I Try?" with Marc Koska
|
Apr 27, 2022 |
|
029 - "Purpose" with Marla Phillips
|
Apr 20, 2022 |
|
028 - "How Much Does Poor Quality Cost?" with H. James Harrington
|
Apr 13, 2022 |
|
027 - "Become a Historian of the Problem" with Duane Mancini
|
Apr 06, 2022 |
|
026 - "Quality" with H. James Harrington
|
Mar 30, 2022 |
|
025 - “The Frying Pan to the Fire” with Edwin Bills
|
Mar 23, 2022 |
|
024 - "Operating Under Constraints "with Naveen Agarwal
|
Mar 16, 2022 |
|
023 - "The Best is Yet to Come" with David Albert
|
Mar 09, 2022 |
|
022 - "What Chapter are you in?" with Susan Neadle
|
Mar 02, 2022 |
|
021 - "Options" with Karandeep Singh Badwal
|
Feb 23, 2022 |
|
020- "The Right Words" with Kathy Walsh
|
Feb 16, 2022 |
|
019 - "Carrying The Bag" with Omar M Khateeb
|
Feb 09, 2022 |
|
018 - "The Optimist Plans for Forever" - with Sarfaraz Niazi
|
Feb 02, 2022 |
|
017 - "Feet First" with Ahmed Zobi
|
Jan 26, 2022 |
|
016 - "Be More Specific" with Joe Hage
|
Jan 19, 2022 |
|
015 - "Would You Use it on a Family Member?" with Monir El Azzouzi
|
Jan 19, 2022 |
|
014A - "The First P: Product" with Larry Mager
|
Jan 05, 2022 |
|
014B - "The Second P: Process" with Larry Mager
|
Jan 05, 2022 |
|
014C - "The Final P: People" with Larry Mager
|
Jan 05, 2022 |
|
013 - “Big Rocks and Little Rocks” with Jumha Abu-Razeq
|
Dec 29, 2021 |
|
012 - "Asking then Seeing" with Sara Waxberg Mcnew
|
Dec 22, 2021 |
|
011 - “Long Story Short” with Margot Leitman
|
Dec 15, 2021 |
|
010 - "Don't Make Assumptions" with David Simoens
|
Dec 08, 2021 |
|
009 - “Cutting Through the Noise” with Charles Ventura
|
Dec 01, 2021 |
|
008 - "Follow the Opportunity" with Marta New
|
Nov 24, 2021 |
|
007 - "Beyond The Obvious" with Miiri Kotche
|
Nov 17, 2021 |
|
006 - “The Courage to Start” with John Bingham
|
Nov 10, 2021 |
|
005 - “Compassionate Product Development” with Cameron Jones
|
Nov 03, 2021 |
|
004 - “Until They Know How Much You Care” with Andy Robertson
|
Oct 27, 2021 |
|
003 - “Standard Understanding” with Mark Swanson
|
Oct 20, 2021 |
|
002 - “Seeing David in the Stone: Predictive Quality Management” with Larry Mager
|
Oct 14, 2021 |
|
001 - “Learning Never Exhausts the Mind” with Rick Doe
|
Oct 06, 2021 |